[1]
“Tissue plasminogen activator (tPA) treatment for COVID_19 associated acute respiratory distress syndrome (ARDS): A case report”, Bangladesh Crit Care J, vol. 9, no. 1, pp. 49–51, Apr. 2021, doi: 10.3329/bccj.v9i1.53059.